月K · MACD · 年ROE Monthly Trend · 美元
MACD(12,26,9)
MACD · 前复权口径
年ROE(每份年报一根整柱,柱宽 = 生效期:报告期 + 4 个月起)
加载中…
获利能力 Profitability (单位:美元)
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 净资产收益率(ROE) | - | 17.56% | 17.68% | 16.88% | 17.43% | 19.64% | 20.60% | 17.12% | 22.06% | 22.86% | 20.97% | 18.45% | 36.33% | 33.37% | 39.25% | 35.23% | 35.11% | 28.59% | 27.12% | 25.28% | 10.72% | 14.81% |
| 总资产收益率(ROA) | - | 8.30% | 8.86% | 9.00% | 9.86% | 10.80% | 10.39% | 8.64% | 11.55% | 12.94% | 12.36% | 10.67% | 21.07% | 17.34% | 22.26% | 20.00% | 17.31% | 16.34% | 18.10% | 17.24% | 7.23% | 8.48% |
| 毛利率 | 28.32% | 30.27% | 29.45% | 29.88% | 29.25% | 28.43% | 27.74% | 28.62% | 28.95% | 29.53% | 29.26% | 30.97% | 31.13% | 31.85% | 33.73% | 35.98% | 35.84% | 35.28% | 35.14% | 32.54% | 31.69% | 32.86% |
| 净利率 | 4.97% | 5.82% | 5.86% | 6.20% | 6.39% | 6.34% | 6.24% | 5.46% | 6.82% | 7.14% | 6.90% | 5.89% | 11.53% | 11.34% | 15.36% | 12.55% | 11.69% | 12.03% | 12.42% | 10.48% | 9.82% | 10.07% |
| 每股收益(EPS) | 1.94 | 2.61 | 2.92 | 3.29 | 3.62 | 4.19 | 4.72 | 4.24 | 5.79 | 6.54 | 6.64 | 6.11 | 12.80 | 13.77 | 20.02 | 17.14 | 16.72 | 18.11 | 20.10 | 18.42 | 8.51 | 9.98 |
财务结构 Financial Structure
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金占总资产比率 | - | 0.65% | 0.48% | 13.72% | 6.01% | 4.78% | 8.09% | 9.45% | 1.64% | 1.73% | 1.74% | 1.21% | 0.50% | 0.49% | 11.34% | 2.45% | 5.14% | 15.82% | 10.69% | 4.84% | 14.55% | 2.55% |
| 负债占总资产比率 | - | 52.70% | 47.76% | 41.77% | 44.34% | 48.02% | 47.27% | 49.77% | 47.51% | 39.78% | 40.45% | 41.27% | 39.38% | 42.71% | 37.19% | 53.58% | 44.61% | 33.58% | 32.94% | 36.33% | 30.23% | 47.42% |
经营能力 Operating Capability
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 应收账款周转率(次) | - | 10.87 | 11.71 | 22.26 | 11.33 | 17.40 | 15.32 | 15.40 | 11.69 | 14.52 | 11.94 | 14.67 | 14.92 | 13.48 | 16.39 | 15.59 | 15.31 | 12.48 | 14.20 | 13.86 | 6.85 | 7.05 |
| 平均收现日数 | - | 34 天 | 31 天 | 16 天 | 32 天 | 21 天 | 24 天 | 24 天 | 31 天 | 25 天 | 31 天 | 25 天 | 24 天 | 27 天 | 22 天 | 23 天 | 24 天 | 29 天 | 26 天 | 26 天 | 53 天 | 52 天 |
| 固定资产周转率(次) | - | 0.0677 | 0.0670 | 0.0633 | 0.0619 | 0.0612 | 0.0643 | 0.0658 | 0.0723 | 0.0760 | 0.0769 | 0.0858 | 0.0909 | 0.0907 | 0.0903 | 0.0905 | 0.0935 | 0.0900 | 0.0826 | 0.0813 | 0.1598 | 0.1567 |
| 总资产周转率 | - | 142.80% | 151.25% | 145.24% | 154.25% | 170.37% | 166.36% | 158.14% | 169.35% | 181.08% | 179.18% | 181.16% | 182.74% | 152.84% | 144.93% | 159.32% | 148.05% | 135.75% | 145.71% | 164.48% | 73.68% | 84.25% |
现金流量 Cash Flow (单位:亿美元)
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金及现金等价物 | - | 0.05 | 0.04 | 1.12 | 0.50 | 0.38 | 0.70 | 0.84 | 0.14 | 0.15 | 0.15 | 0.11 | 0.05 | 0.06 | 1.63 | 0.33 | 0.74 | 2.64 | 1.78 | 0.75 | 2.50 | 0.40 |
| 净利润 | 0.51 | 0.64 | 0.67 | 0.74 | 0.82 | 0.86 | 0.89 | 0.77 | 0.99 | 1.10 | 1.09 | 0.98 | 2.06 | 2.20 | 3.19 | 2.69 | 2.50 | 2.73 | 3.02 | 2.65 | 1.24 | 1.34 |
| 经营活动现金流量 | 0.99 | 1.00 | 1.12 | 1.61 | 0.86 | 1.74 | 1.32 | 1.51 | 1.10 | 1.72 | 1.35 | 1.62 | 2.87 | 3.01 | 4.89 | 3.09 | 3.10 | 3.30 | 4.17 | 3.88 | 1.71 | 1.73 |
| 投资活动现金流量 | -0.28 | -0.32 | -0.29 | -0.23 | -0.36 | -0.34 | -0.41 | -0.31 | -0.44 | -0.50 | -0.40 | -0.68 | -1.05 | -1.91 | -0.62 | -0.58 | -0.59 | -0.61 | -1.44 | -0.59 | -0.29 | -0.66 |
| 筹资活动现金流量 | -0.99 | -0.92 | -0.85 | -0.29 | -1.13 | -1.52 | -0.60 | -1.05 | -1.37 | -1.21 | -0.95 | -0.99 | -1.88 | -1.09 | -2.71 | -3.81 | -2.09 | -0.80 | -3.59 | -4.33 | -0.71 | -1.41 |
| 净现金流量 | -0.28 | -0.24 | -0.01 | 1.09 | -0.62 | -0.12 | 0.31 | 0.15 | -0.70 | 0.01 | 0.01 | -0.04 | -0.06 | 0.01 | 1.57 | -1.30 | 0.41 | 1.90 | -0.86 | -1.04 | 0.72 | -0.34 |
右侧两列为报告期累计口径同比(左:去年同期同一期次,右:最近一期季报,年报期次已在左侧列展示);周转率类指标为报告期累计值,未做年化。
医疗保健
- 近五年ROE对比
1
100.00%
PACS Group Inc
次新股
PACS
2
100.00%
ImmunityBio Inc
亏损年份
IBRX
3
100.00%
安进
AMGN
4
100.00%
奥洛兹美医疗
HALO
5
100.00%
Puma Biotechnology Inc
亏损年份
PBYI
6
100.00%
沃特世
WAT
7
100.00%
Picard Medical Inc
数据<5年
亏损年份
次新股
PMI
8
84.37%
IDEXX实验室
IDXX
9
79.94%
泰尼特保健
THC
10
74.93%
礼来
LLY
11
74.56%
诺和诺德
NVO
12
62.37%
BridgeBio Pharma Inc
亏损年份
BBIO
13
52.47%
硕腾
ZTS
14
50.94%
NRC Health
NRC
15
49.16%
Medpace Holdings Inc
MEDP
16
48.89%
葛兰素史克
GSK
17
32.44%
Harmony Biosciences Holdings In
HRMY
18
32.16%
Innoviva Inc
INVA
19
31.55%
强生
JNJ
20
30.84%
默沙东
MRK
21
30.27%
Chemed Corp
CHE
22
29.98%
InMode Ltd
INMD
23
28.48%
西佳科技
SIGA
24
27.65%
爱德华兹生命科学
EW
25
26.99%
诺华制药
NVS
26
25.87%
Catalyst Pharmaceuticals Inc
CPRX
27
24.94%
Molina Healthcare Inc
MOH
28
24.45%
再生元制药
REGN
29
24.38%
吉利德科学
GILD
30
24.35%
瑞思迈
RMD